NovoSeven

DRUG3 trials

Sponsors

Medical University of Vienna, AryoGen Pharmed Co., Universiti Sains Malaysia

Conditions

Factor VII DeficiencyHemophilia AMassive Blood LossMassive Blood Transfusion; ThrombocytopeniaMassive Hemorrhage

Phase 3

Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation

CompletedNCT00375323

Medical University of ViennaHemophilia A

Updated: 2007-04-20

Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency

CompletedNCT03079063

AryoGen Pharmed Co.Factor VII Deficiency

Start: 2017-03-01End: 2021-01-28Updated: 2021-02-04

Unknown Phase

Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains Malaysia

CompletedNCT03251547

Universiti Sains MalaysiaMassive Blood Loss, Massive Blood Transfusion; Thrombocytopenia, Massive Hemorrhage

Start: 2017-08-21End: 2017-11-15Updated: 2018-10-10